Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
BRASILIA (Reuters) — Brazil's Butantan Institute biomedical center will receive this week the first doses of China's Sinovac vaccine against COVID-19, its director, Dimas Covas, said on Tuesday, speaking remotely in a congressional hearing.
Covas said the preliminary results of the trials Butantan is conducting in Brazil indicate the vaccine, called CoronaVac, has an excellent safety profile. He said Butantan expects to have 46 million doses ready for use in January.
(Reporting by Anthony Boadle and Maria Carolina Marcello; editing by Jonathan Oatis)
© Copyright Thomson Reuters 2020
